Karuna Therapeutics, Inc.
(NASDAQ : KRTX)

( )
KRTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.16%162.160.7%$1270.30m
LLYEli Lilly & Co. 0.50%334.461.1%$1111.09m
ABBVAbbVie, Inc. 0.01%140.301.9%$860.61m
PFEPfizer Inc. 0.16%43.180.9%$804.94m
BMYBristol-Myers Squibb Co. -0.04%70.211.0%$751.47m
MRKMerck & Co., Inc. -0.26%87.200.7%$695.74m
AZNAstraZeneca Plc 1.95%55.981.0%$393.72m
ALNYAlnylam Pharmaceuticals, Inc. 0.00%202.378.2%$224.83m
GSKGSK Plc 1.70%30.510.3%$212.06m
NVSNovartis AG 0.54%76.450.2%$201.99m
HZNPHorizon Therapeutics Plc 0.00%67.895.4%$188.70m
IDXXIDEXX Laboratories, Inc. 0.00%346.023.9%$184.33m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$178.81m
SRPTSarepta Therapeutics, Inc. 0.00%114.8212.4%$141.73m
AKROAkero Therapeutics, Inc. 0.00%39.260.0%$134.17m

Company Profile

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.